10 Health Care Stocks With Whale Alerts In Today's Session
Clinical Development Expertise Aids IQVIA (IQV), Costs High
Investors in IQVIA Holdings (NYSE:IQV) Have Seen Respectable Returns of 31% Over the Past Five Years
5 Analysts Assess IQVIA Hldgs: What You Need To Know
IQVIA Holdings Is Maintained at Overweight by Barclays
Express News | IQVIA Holdings Inc : Barclays Cuts Target Price to $255 From $275
Barclays Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $255
Barclays Lowers Price Target on IQVIA Holdings to $255 From $275
Unusual Options Activity: MTCH, CMCSA and Others Attract Market Bets, MTCH V/OI Ratio Reaches 273.9
Goldman's Top 50 High Sharpe Ratio Stocks
Insiders At IQVIA Holdings Sold US$9.2m In Stock, Alluding To Potential Weakness
IQVIA's SmartSolve EQMS Wins 2024 MedTech Breakthrough Award "Best Use of Artificial Intelligence in Healthcare"
How Is IQVIA Holdings' Stock Performance Compared to Other Healthcare Stocks?
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today
Long-term Beneficiaries of AI, According to Goldman Sachs
Gilead Stock Gains. It's Trying to Get Into the Obesity Drug Game.
Express News | IQVIA Holdings Inc : Baird Cuts Target Price to $241 From $245
Express News | IQVIA Launches “One Home” Clinical Trial Technology Platform – Solves Challenges and Reduces Overload at Sites
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?
A Closer Look At IQVIA Holdings Inc.'s (NYSE:IQV) Impressive ROE